• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肝细胞癌中,Oct4通过LEF1/β-连环蛋白依赖性WNT信号通路诱导上皮-间质转化。

Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling pathway in hepatocellular carcinoma.

作者信息

Sun Lu, Liu Tianhua, Zhang Shu, Guo Kun, Liu Yinkun

机构信息

Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion, Fudan University, Ministry of Education, Shanghai 200032, P.R. China.

Institute of Biomedical Sciences, Fudan University, Shanghai 200032, P.R. China.

出版信息

Oncol Lett. 2017 Apr;13(4):2599-2606. doi: 10.3892/ol.2017.5788. Epub 2017 Feb 28.

DOI:10.3892/ol.2017.5788
PMID:28454439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5403449/
Abstract

Octamer 4 (Oct4), a member of the Pit-Oct-Unc transcription factor family required to maintain self-renewal and pluripotency of embryonic stem cells, has been previously identified to be associated with tumorigenesis and malignant transformation of numerous types of cancer including hepatocellular carcinoma (HCC). The present data shows that Oct4 enhances cancer stem cell properties and increases invasion ability in the Huh7 cell line. To increase understanding of the role of Oct4 in HCC, the present study used a functional genomics approach and analyzed the resulting transcriptional profiles to identify Oct4-dependent genes in Huh7. Affymetrix GeneChip Human genome U133 Plus 2.0 Arrays were used to determine differential gene expression profiles and then validated by quantitative polymerase chain reaction. The present study found that altered expression of 673 genes (fold-change ≥2) affected multiple signaling pathways linked with self-renew and metastasis. Among these differentially expressed genes, the present study noticed that the key component of the WNT signaling pathway lymphoid enhancer binding factor 1 (LEF1) and Twist Family BHLH transcription factor 1 were upregulated by Oct4, whilst cadherin 2 was downregulated. Additional studies found that the nuclear β-catenin aggregation was increased in Oct4 overexpressed HCC cell lines. These results suggest that Oct4 regulates LEF1 to active LEF1/β-catenin dependent WNT signaling pathway and promote epithelial-mesenchymal transition. The present findings provide novel mechanistic insight into an important role of Oct4 in HCC.

摘要

八聚体4(Oct4)是维持胚胎干细胞自我更新和多能性所需的Pit-Oct-Unc转录因子家族成员,此前已被确定与包括肝细胞癌(HCC)在内的多种癌症的肿瘤发生和恶性转化有关。目前的数据表明,Oct4增强了肝癌细胞系Huh7的癌症干细胞特性并提高了其侵袭能力。为了加深对Oct4在肝癌中作用的理解,本研究采用功能基因组学方法并分析所得转录谱,以鉴定Huh7中Oct4依赖性基因。使用Affymetrix GeneChip人类基因组U133 Plus 2.0芯片来确定差异基因表达谱,然后通过定量聚合酶链反应进行验证。本研究发现,673个基因(倍数变化≥2)的表达改变影响了与自我更新和转移相关的多个信号通路。在这些差异表达基因中,本研究注意到WNT信号通路的关键成分淋巴样增强因子结合因子1(LEF1)和Twist家族BHLH转录因子1被Oct4上调,而钙黏蛋白2被下调。进一步的研究发现,在Oct4过表达的肝癌细胞系中,核β-连环蛋白聚集增加。这些结果表明,Oct4通过调节LEF1激活LEF1/β-连环蛋白依赖性WNT信号通路并促进上皮-间质转化。本研究结果为Oct4在肝癌中的重要作用提供了新的机制性见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/0263f6d2d0c7/ol-13-04-2599-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/6552fcdb018a/ol-13-04-2599-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/4181efe36211/ol-13-04-2599-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/1a17125dfae8/ol-13-04-2599-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/0263f6d2d0c7/ol-13-04-2599-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/6552fcdb018a/ol-13-04-2599-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/4181efe36211/ol-13-04-2599-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/1a17125dfae8/ol-13-04-2599-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/76c4/5403449/0263f6d2d0c7/ol-13-04-2599-g03.jpg

相似文献

1
Oct4 induces EMT through LEF1/β-catenin dependent WNT signaling pathway in hepatocellular carcinoma.在肝细胞癌中,Oct4通过LEF1/β-连环蛋白依赖性WNT信号通路诱导上皮-间质转化。
Oncol Lett. 2017 Apr;13(4):2599-2606. doi: 10.3892/ol.2017.5788. Epub 2017 Feb 28.
2
Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.基因Oct4和Nanog的共表达启动了肝细胞癌中的干细胞特征,并通过激活Stat3/Snail信号通路促进上皮-间质转化。
J Hematol Oncol. 2015 Mar 11;8:23. doi: 10.1186/s13045-015-0119-3.
3
Repression of WT1-Mediated LEF1 Transcription by Mangiferin Governs β-Catenin-Independent Wnt Signalling Inactivation in Hepatocellular Carcinoma.芒果苷对WT1介导的LEF1转录的抑制作用调控肝细胞癌中β-连环蛋白非依赖性Wnt信号通路失活
Cell Physiol Biochem. 2018;47(5):1819-1834. doi: 10.1159/000491063. Epub 2018 Jun 28.
4
Lymphoid Enhancer Factor 1 Contributes to Hepatocellular Carcinoma Progression Through Transcriptional Regulation of Epithelial-Mesenchymal Transition Regulators and Stemness Genes.淋巴增强因子1通过对上皮-间质转化调节因子和干性基因的转录调控促进肝细胞癌进展。
Hepatol Commun. 2018 Sep 28;2(11):1392-1407. doi: 10.1002/hep4.1229. eCollection 2018 Nov.
5
SNAIL1 employs β-Catenin-LEF1 complexes to control colorectal cancer cell invasion and proliferation.SNAIL1 通过 β-Catenin-LEF1 复合物来控制结肠直肠癌的侵袭和增殖。
Int J Cancer. 2020 Apr 15;146(8):2229-2242. doi: 10.1002/ijc.32644. Epub 2019 Sep 18.
6
MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway.MicroRNA-194 通过 PRC1 介导的抑制 Wnt/β-catenin 信号通路抑制肝癌细胞侵袭和迁移。
Dig Liver Dis. 2019 Sep;51(9):1314-1322. doi: 10.1016/j.dld.2019.02.012. Epub 2019 Mar 1.
7
Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling.Kindlin-2 通过增加 Wnt/β-catenin 信号促进肝癌侵袭和转移。
J Exp Clin Cancer Res. 2017 Sep 29;36(1):134. doi: 10.1186/s13046-017-0603-4.
8
A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.Wnt-β-连环蛋白信号通路与肝细胞核因子4α之间的双负反馈回路调节肝细胞癌中的上皮-间质转化。
J Cell Sci. 2013 Dec 15;126(Pt 24):5692-703. doi: 10.1242/jcs.135053. Epub 2013 Oct 7.
9
NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma.NTS/NTR1共表达通过激活肝细胞癌中的Wnt/β-连环蛋白信号通路增强上皮-间质转化并促进肿瘤转移。
Oncotarget. 2016 Oct 25;7(43):70303-70322. doi: 10.18632/oncotarget.11854.
10
Role of Lef1 in sustaining self-renewal in mouse embryonic stem cells.Lef1 在维持小鼠胚胎干细胞自我更新中的作用。
J Genet Genomics. 2010 Jul;37(7):441-9. doi: 10.1016/S1673-8527(09)60063-1.

引用本文的文献

1
Unlocking the Role of OCT4 in Cancer Lineage Plasticity: A Cross-Cancer Perspective with an Emphasis on Prostate Cancer.揭示OCT4在癌症谱系可塑性中的作用:跨癌症视角,重点关注前列腺癌。
Biomedicines. 2025 Jul 4;13(7):1642. doi: 10.3390/biomedicines13071642.
2
Exploring RNA binding proteins in hepatocellular carcinoma: insights into mechanisms and therapeutic potential.探索肝细胞癌中的RNA结合蛋白:对其机制及治疗潜力的见解
J Exp Clin Cancer Res. 2025 Apr 24;44(1):130. doi: 10.1186/s13046-025-03395-7.
3
Multifaceted roles of OCT4 in tumor microenvironment: biology and therapeutic implications.

本文引用的文献

1
Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.Oct4和ABCG2与CD90(+)CD133(+)肝癌干细胞化疗耐药性的正相关
Cell Reprogram. 2013 Apr;15(2):143-50. doi: 10.1089/cell.2012.0048. Epub 2013 Feb 25.
2
Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.OCT4 的高表达与人类肝细胞癌的低分化和肿瘤复发相关。
Pathol Res Pract. 2012 Sep 15;208(9):527-33. doi: 10.1016/j.prp.2012.05.019. Epub 2012 Jul 21.
3
Coexpression of stemness factors Oct4 and Nanog predict liver resection.
OCT4在肿瘤微环境中的多方面作用:生物学及治疗意义
Oncogene. 2025 May;44(18):1213-1229. doi: 10.1038/s41388-025-03408-x. Epub 2025 Apr 14.
4
Integrative analysis of exosomal ncRNAs and their regulatory networks in liver cancer progression.外泌体非编码RNA及其调控网络在肝癌进展中的综合分析
Pract Lab Med. 2025 Mar 21;45:e00464. doi: 10.1016/j.plabm.2025.e00464. eCollection 2025 Jul.
5
Stigmasterol Attenuates Triple-negative Breast Cancer Stem Cell Properties by Inhibiting JAK3.豆甾醇通过抑制JAK3减轻三阴性乳腺癌干细胞特性。
J Cancer. 2025 Feb 3;16(5):1618-1630. doi: 10.7150/jca.94822. eCollection 2025.
6
Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p.假基因 OCT4-pg5 通过与 miR-145-5p 竞争上调 OCT4B 的表达来促进膀胱癌的进展。
Cell Cycle. 2024 Mar;23(6):645-661. doi: 10.1080/15384101.2024.2353554. Epub 2024 Jun 6.
7
Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment.八聚体结合转录因子 4 阳性循环肿瘤细胞预测接受免疫检查点抑制剂治疗的晚期胆管癌患者治疗反应和生存更差。
World J Surg Oncol. 2024 Apr 25;22(1):110. doi: 10.1186/s12957-024-03369-7.
8
Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway.钠/碘同向转运体过表达通过抑制β-连环蛋白/淋巴样增强因子1信号通路在抑制甲状腺癌细胞侵袭和维持干细胞特性中的作用
Heliyon. 2024 Mar 14;10(6):e27840. doi: 10.1016/j.heliyon.2024.e27840. eCollection 2024 Mar 30.
9
Wnt/β-catenin-driven EMT regulation in human cancers.Wnt/β-catenin 驱动的人类癌症中的 EMT 调控。
Cell Mol Life Sci. 2024 Feb 9;81(1):79. doi: 10.1007/s00018-023-05099-7.
10
Downregulation of MAL2 inhibits breast cancer progression through regulating β-catenin/c-Myc axis.MAL2的下调通过调节β-连环蛋白/c-Myc轴抑制乳腺癌进展。
Cancer Cell Int. 2023 Jul 21;23(1):144. doi: 10.1186/s12935-023-02993-9.
干性因子 Oct4 和 Nanog 的共表达预测肝切除术。
Ann Surg Oncol. 2012 Sep;19(9):2877-87. doi: 10.1245/s10434-012-2314-6. Epub 2012 Mar 30.
4
Role of Sox2 and Oct4 in predicting survival of hepatocellular carcinoma patients after hepatectomy.Sox2 和 Oct4 在预测肝癌患者肝切除术后生存中的作用。
Clin Biochem. 2011 Jun;44(8-9):582-9. doi: 10.1016/j.clinbiochem.2011.02.012. Epub 2011 Mar 1.
5
Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.Oct4 和 Nanog 的共表达通过诱导癌症干细胞样特性和上皮-间充质转化增强肺腺癌的恶性程度。
Cancer Res. 2010 Dec 15;70(24):10433-44. doi: 10.1158/0008-5472.CAN-10-2638.
6
Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.八聚体结合蛋白 4(Oct4)通过潜在的 Oct4-AKT-ATP 结合盒 G2 通路介导肝癌细胞的化疗耐药性。
Hepatology. 2010 Aug;52(2):528-39. doi: 10.1002/hep.23692.
7
An expanded Oct4 interaction network: implications for stem cell biology, development, and disease.扩展的 Oct4 相互作用网络:对干细胞生物学、发育和疾病的影响。
Cell Stem Cell. 2010 Apr 2;6(4):382-395. doi: 10.1016/j.stem.2010.03.004.
8
Eset partners with Oct4 to restrict extraembryonic trophoblast lineage potential in embryonic stem cells.埃斯韦特与八聚体结合转录因子4合作,限制胚胎干细胞中胚外滋养层谱系的潜能。
Genes Dev. 2009 Nov 1;23(21):2507-20. doi: 10.1101/gad.1831909.
9
MicroRNA regulation of cancer stem cells and therapeutic implications.微小 RNA 对癌症干细胞的调控及其治疗意义。
AAPS J. 2009 Dec;11(4):682-92. doi: 10.1208/s12248-009-9147-7. Epub 2009 Oct 20.
10
Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate.Oct4 与 Sox2 和 Sox17 的相互作用:从干细胞多能性到确定心脏命运的分子开关。
J Cell Biol. 2009 Sep 7;186(5):665-73. doi: 10.1083/jcb.200901040.